Baijin Life Science Holdings Ltd (HKSE:01466) Share Price

Company Profile

Business description
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company produces health products that are affordable for the general public. The business segments of the company are Life Science segment which includes cellular technology-based services, provide including cellular drugs R&D, large molecule drugs R&D, clinical research services and R&D and sales on self-owned skincare brand, and Fine Jewelry segment that focuses on the procurement, processing, design, production and wholesale distribution of pearls and fine jewelry products.
Contact
66 Gloucester Road
Office B, 9/F Pico Tower
Wanchai
Hong Kong
HKG
T: +852 36112188
http://www.affluent-partners.com
Sector
Consumer Cyclical
Stock type
Cyclical
Industry
Luxury Goods
Fiscal Year End
31 March 2026
Employees
84

Recommended

We were wrong when we thought last quarter would be hard to top.

Dan Romanoff, CPA | 31 July 2025

These undervalued stocks with wide and narrow moats have increased their dividends for 25 consecutive years or more.

Susan Dziubinski | 30 July 2025

We raise our Fair Value estimates but still think that current share prices rely on overly optimistic expectations.

Shaun Ler | 30 July 2025

Index	Last price	Change	% Change
All Ordinaries	8,999.00	16.40	-0.18%
CAC 40	7,838.45	23.51	-0.30%
DAX 40	24,286.39	24.17	0.10%
Dow JONES (US)	44,461.28	171.71	-0.38%
FTSE 100	9,156.69	19.75	0.22%
HKSE	24,773.33	403.60	-1.60%
NASDAQ	21,129.67	31.38	0.15%
Nikkei 225	41,069.82	415.12	1.02%
NZX 50 Index	12,823.74	32.23	-0.25%
S&P 500	6,362.90	7.96	-0.12%
S&P/ASX 200	8,742.80	13.60	-0.16%
SSE Composite Index	3,573.21	42.51	-1.18%